ComplianceOnline

Detection of PCV1 Virus Caused Temporary Suspension of Rotarix Vaccine

  • Date: March 23, 2010
  • Source: Admin
Webinar All Access Pass Subscription Abstract:

FDA is requiring the healthcare practitioners to temporarily stop using Rotarix vaccine, manufactured by GlaxoSmithKline (GSK) for rotavirus immunization in the US, as the FDA wishes to learn more about components of a superfluous virus detected in the vaccine. However, there is no evidence at this time that this finding poses a safety risk.


 

Bookmark and Share
Best Sellers
You Recently Viewed
    Loading